There was no difference in the incidence of birth trauma [3 (6%) vs 6 (12%); p=0.29], shoulder dystocia [ 7 (14%) vs 5 (10%); p=0.53], birth asphyxia [17 (34%) vs 18 (36%); p=0.83], neonatal jaundice [22 (44%) vs 21 (42%); p=0.84], admission to special new born care unit [27 (54%) vs 30 (60%), p=0.54] and congenital anomaly [1 (2%) vs 0%; p=0.31] between patients treated with insulin versus acarbose respectively (Figure 3). This evidence concerns the gene INS and neonatal jaundice.